drugset / Trial / NCT06725355

To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers

NCT06725355 ↗

Phase 1 Active not recruiting 60 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetics and safety after a single dose administration of IN-G00002 and IN-R00002 in healthy adult volunteers

Timeline

Start
2024-08-16
Primary completion
2024-10-08
Completion
2025-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-G00002 Unknown 60 mg —
Subject IN-R00002 Unknown 60 mg —

Indications